Gene and Cell Therapy
Gene therapy is a way to treat the genetic disorders. The variation in gene therapy is focused on somatic gene therapy and germ line gene therapy relating with viral and non-viral vectors. T-cells are the type of lymphocyte cells which are developed in the laboratory to attack the cancer cells. T-cell therapy is nothing but an immune therapy to treat certain kinds of cancer. The nano therapy is a new trend in the field of medicine which uses nanoparticles to delivery drugs to the targeted body part.
- Diseases treated using Gene therapy
- Risks in gene therapy
- T-cell therapy
- Nano therapy and nano materials in treating diseases
- Application of Nano-materials
- Ethical Issues of Stem Cell based Gene Therapy
Related Conference of Gene and Cell Therapy
November 17-18, 2025
18th International Conference on Human Genomics and Genomic Medicine
Paris, France
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Gene and Cell Therapy Conference Speakers
Recommended Sessions
- 3D Bio-Printing and Organ Printing
- Advanced Gene Therapeutics
- Ageing Theories in Stem Cell
- Biomaterials and Biomedical Applications
- Cell Culture and Bioprocessing
- Clinical Tissues Analysis
- Epigenetics and Stem Biology
- Ethical Issues in Cell and Gene Therapy
- Gene and Cell Therapy
- Genetics & Genomic Medicine
- Genome Editing
- Genome Editing Technology
- Stem Cell and Regenerative Medicine
- Stem Cell Apoptosis and Signal Transduction
- Stem Cell Research
- Tissue Engineering and 3D Cell Culture
- Tissue-Engineered Disease Models
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)